Viruses I Flashcards

(36 cards)

1
Q

Basic viral outcomes in host cells (2)

A
  1. cytolytic:
    causes cell lysis of host cell (permanent damage)
  2. immunopathology:
    present virus peptides (HLA-1) –> immunologically induced cell lysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

polio vaccines

A
  1. IPV - (chemically) Inactivated Polio Virus vaccine, by injection.
    • use ONLY IPV in USA. No replication – need 3 doses.
      NO spread, does not block fecal-oral spread.
  2. OPV - Oral Polio Virus vaccine (live, attenuated virus), by dropper bottle.
    Does replicate - single dose = effective.
    • Excretion of live virus soon after vaccination.
      ==> both induce humoral immunity for serotypes 1 and 3 (not 2),
      (antibodies that intercept polio before clinical disease occurs)
      * given at age: 2 months - 6 years*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Polio virus (PV) characteristics

A

small, non-enveloped icosahedral virus; + polarity, SS RNA;
* cytolytic infection*
humans = only natural host, 3 serotypes.
preferentially replicate in anterior horn of spinal cord
(damages motor neurons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Polio virus replication process

A

Host ribosomes immediately translate viral RNA…
–> a) protein intermediate that allows further translation (more mRNA) AND b) viral RNA replication (at same time)
Requires:
- full-length complementary strand RNA
- PV-encoded RNA polymerase;
–> multiple virus populations w/ distinct sequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Polio virus clinical presentation

A

transmission: fecal-oral
Disease states:
- abortive ppoliomyelitis: mild febrile illness
- nonparalytic poliomyelitis: aseptic meningitis (self-resolving)
- paralytic poliomyelitis: flaccid paralysis (permanent motor damage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Post-Polio Syndrome

A

Secondary effects of polio, appear 40-60 years after initial infection; (affects 50% of polio patients)
==> neurological condition of fatigue + renewed weakness in originally affected muscles
* mech. unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Measles virus characteristics

A

negative polarity SS RNA, enveloped;
single serotype “paramyxovirus”;
* characteristic surface spikes (hemagglutinin and fusion/hemolytic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Respiratory Syncytium Virus (RSV) characteristics

A

a paramyxovirus, structure and function similar to measles (but not hemagglutinin);
Replication: same as measles.
* antiviral Ab targets fusion proteins*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Respiratory Syncytium Virus Infection

A

–> Bronchiolitis (w/ mucosal necrosis); otitis media, or pneumonia (in elderly)
1-4 day incubation, 10-14 day acute illness
– wheezing, cough, respiratory distress, +/- fever
* mostly in young children, can be fatal in neonates
** prophylactic treatment w/ Ribavirin (inhibits viral RNA replication)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parainfluenza Virus

A

4 serotypes, a paramyxovirus;
structurally/functionally similar to measles.
==> croup (narrowing of airway –> “barking”/hoarseness)
* mostly in very young children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Human Metapneumovirus (hMPV)

A

paramyxovirus, similar to measles;
==> severe bronchiolitis or pneumonia in young or elderly
OR common cold in others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rhinovirus

A

picornavirus (similar structure, f(x), replication to polio virus),
>100 serotypes (very difficult to treat/vaccinate!);
==> #1 for common cold
* optimal temp for replication: 33C (Not GI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coronavirus

A

+ polarity SS RNA, enveloped, multiple serotypes.
==> common cold / lower resp. tract infections
** SARS (Severe Acute Respiratory Syndrome)**
60% case fatality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SARS (Severe Acute Respiratory Syndrome)

A

Respiratory and GI symptoms (cough, SOB, Dyspnia, rapid decline)
- aerosol transmission w/ close contact
4-7 day incubation, HIGH fatality rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hantavirus

A

aerosol transmission (rodent excretion, NO human-human).

  • -> Korean Hemorrhagic Fever - cough, fever, acute renal failure, 5-10% mortality
  • -> Hantavirus Pulmonary Syndrome - fever, myalgia, headache, cough, edema, interstitial inflammatory infiltrates – hypoxia
  • 60% mortality!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hendra and Nipah viruses

A

aerosol transmission,
==> high fever and encephalitis
- hendra: Australia (from fruit bats)
- Nipah: Malaysia (in pigs and people)

17
Q

influenza virus

A

Neg. polarity SS RNA, 8 segments (need all 8)
From aquatic birds –> pigs, people;
* 2 genetic phenomenon:
- antigenic drift and shift

18
Q

Antigenic Shift

A

major change in viral genome from reassortment of gene segments from mixed infection (by 2+ influenza viruses w/ ~unique genomes)

19
Q

flow of genetic material for retroviruses

A

RNA –> DNA –> RNA –> Protein
* uses reverse transcriptase (“RT”)
= RNA(or DNA)-dependent DNA polymerase

20
Q

Retrovirus Virion genome

A

2 identical SS RNA, + polarity, enveloped.
* virion RNAs are NEVER translated (into protein)
(–> used to make cDNA by Reverse transcriptase)

21
Q

diagnostic signs of ATL (Adult T cell Leukemia)

A
  • unusual “flower” cell forms
  • aberrant proliferation of T cells
    (CD4:CD8 ratio MUCH higher than normal, ie: 5-10)
  • Cutaneous lymphoma (“mycosis fungoides”)
22
Q

Viruses associated with HIV/AIDS infection

A

(= secondary infections bc immunocompromised)

  • herpes simplex virus 1 and 2; herpes virus
  • cytomegalovirus
  • varicella zoster virus
  • epstein barr virus
  • Kaposi’s sarcoma (skin tumors)
23
Q

Fungi associated with HIV/AIDS infection

A

(= secondary infection, bc immunocompromised)

  • Candida albicans –> thrush
  • pneumocystis jiroveci –> “PCP” severe pneumonia
  • cryptococcus neoformans
  • aspergillus
  • coccidiodes immitus (liver)
  • histoplasma capsulatum (macrophages in liver)
24
Q

Bacteria associated with HIV/AIDS infection

A

(secondary infection bc of immunosuppresion)

  • mycobacterium tuberculosis, avium
  • salmonella
  • streptococci
  • staphylococci
  • haemophilus influenzae
25
Protozoa associated with HIV/AIDS infection
(secondary infection bc of immunosuppression) - toxoplasma gondii - cryptosporidium parvum - helminths
26
types of drugs used for HIV treatment
1. Reverse transcriptase inhibitors a) nucleoside analogs b) non-nucleoside cmpds 2. HIV-1 Protease inhibitors (bc viral protease = diff. than human) 3. CCR5 inhibitor (not ideal) 4. fusion inhibitor (injected, not ideal) 5. Integrase inhibitor
27
8 human Herpes viruses w/ mode of transmission
1, 2. Herpes Simplex (HSV-1, HSV-2) - sex, perinatal 3. varicella zoster (VZV) - aerosol 4. Cytomegalovirus (CMV) - Aerosol, sex/blood 5. Ebstein-Barr virus (EBV) - #1 saliva, sex/blood/perinatal 6, 7. HHV-6, HHV-7 - Saliva, common 8. Kaposi's Sarcoma Herpes Virus (KSHV) - MSM sex
28
Characteristics of Herpes virus infection
--> life-long, quiescent infections (do NOT clear), CAN reactivate w/ or w/OUT symptoms (--> spread) prevent spread: daily acyclovir -- for HSV-1, 2; VZV reactivation
29
Cytomegalic Inclusion Disease (CID)
Congenital disease caused by cytomegalovirus, | --> microcephaly and mental retardation
30
Cytomegalovirus-associated conditions
1. congenital birth defects (#1 hearing loss, seizures, IQ deficit) 2. Cytomegalic Inclusion Disease (microcephaly) 3. Mononucleosis -- in transplant recipients 4. Pneumonitits/Chorioretinitis/Dementia (from reactivation) -- in AIDS patients
31
Sites of latent infection for Herpes viruses
1) HSV and VZV: sensory ganglia 2) CMV: MANY sites (kidney, leukocytes, male reproductive tissue, etc.) 3) EBV: B cells 4) KSHV: Epithelial and B cells
32
exanthum
Any rash accompanied by inflammation that is caused by an infectious process ie: measles, rubella, roseola, ECHO virus
33
Rubella virus characteristics
Togavirus, Enveloped SS RNA, + polarity. * full life-cycle needs sub-genomic mRNA* 1 serotype --> vaccine = part of MMR transmission: aerosol, incubation: 14-21 days
34
Rubella symptoms
Fever, malaise, * maculopapular starts on face and spreads to rest of body (rash comes from viral replication AND immunopathology); resolves in 2-4 days.
35
Congenital Rubella Syndrome (CRS)
Major/severe congenital defects associated with maternal rubella infection in 1st trimester, * worst at earliest stages in pregnancy (ie: 1st month) - -> heart/eye/brain dysfunction, spontaneous abortion, stillbirth
36
Rabies virus characteristics
negative, SS RNA, enveloped. Replication like measles virus. * single serotype! bullet-shaped virion, Rhaabdovirus family transmission by wild animal bites (in any mammals).